138 related articles for article (PubMed ID: 37705525)
1. Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: An Italian Monocentric Experience.
Fazio F; Lapietra G; Limongi MZ; Intoppa S; Milani ML; Piciocchi A; Martelli M; Guarini A; Foà R; De Propris MS; Petrucci MT
Mediterr J Hematol Infect Dis; 2023; 15(1):e2023047. PubMed ID: 37705525
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of cell morphology and immunophenotypic characteristics in 47 cases of multiple myeloma].
Su XD; Lin R; Xu XL; Chen X; Zhan WL; Zheng JP; Fan CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):137-41. PubMed ID: 25687061
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic characterization and quantification of neoplastic bone marrow plasma cells by multiparametric flow cytometry and its clinical significance in Korean myeloma patients.
Cho YU; Park CJ; Park SJ; Chi HS; Jang S; Park SH; Seo EJ; Yoon DH; Lee JH; Suh C
J Korean Med Sci; 2013 Apr; 28(4):542-9. PubMed ID: 23580331
[TBL] [Abstract][Full Text] [Related]
4. [Immunophenotype characteristics of patients with multiple myeloma in different risk stratification].
Hu K; Wang J; Zhu MX; Wang YF; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1624-7. PubMed ID: 25543486
[TBL] [Abstract][Full Text] [Related]
5. Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.
Jeong TD; Park CJ; Shim H; Jang S; Chi HS; Yoon DH; Kim DY; Lee JH; Lee JH; Suh C; Lee KH
Korean J Hematol; 2012 Dec; 47(4):260-6. PubMed ID: 23320004
[TBL] [Abstract][Full Text] [Related]
6. [Expression of CD56 and CD19 in Patients with Newly Diagnosed Multiple Myeloma and Their Relationship with Karyotypes and Prognosis].
Qiu Q; Zhu P; Wang MJ; Lu XZ; Dong YJ; Sun YH; Wang LH; Zhang Y; Bu DF; Wang WS; Liang ZY; Liu W; Qiu ZX; Ou JP; Cen XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1071-8. PubMed ID: 27531777
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of multiparameter flow cytometry immunophenotyping and cytogenetic aberrancies in patients with multiple myeloma.
Guo J; Su J; He Q; Li X; Zhao Y; Gu S; Fei C; Chang C
Hematology; 2016 Apr; 21(3):152-61. PubMed ID: 25860485
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.
Mateo G; Montalbán MA; Vidriales MB; Lahuerta JJ; Mateos MV; Gutiérrez N; Rosiñol L; Montejano L; Bladé J; Martínez R; de la Rubia J; Diaz-Mediavilla J; Sureda A; Ribera JM; Ojanguren JM; de Arriba F; Palomera L; Terol MJ; Orfao A; San Miguel JF; ;
J Clin Oncol; 2008 Jun; 26(16):2737-44. PubMed ID: 18443352
[TBL] [Abstract][Full Text] [Related]
9. [Immunophenotype characteristics in multiple myeloma cells and their significance].
Sun Y; Fang MY; Liu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):381-4. PubMed ID: 20416173
[TBL] [Abstract][Full Text] [Related]
10. CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction.
Skerget M; Skopec B; Zadnik V; Zontar D; Podgornik H; Rebersek K; Furlan T; Cernelc P
Acta Haematol; 2018; 139(4):228-234. PubMed ID: 29920491
[TBL] [Abstract][Full Text] [Related]
11. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.
Rawstron AC; Orfao A; Beksac M; Bezdickova L; Brooimans RA; Bumbea H; Dalva K; Fuhler G; Gratama J; Hose D; Kovarova L; Lioznov M; Mateo G; Morilla R; Mylin AK; Omedé P; Pellat-Deceunynck C; Perez Andres M; Petrucci M; Ruggeri M; Rymkiewicz G; Schmitz A; Schreder M; Seynaeve C; Spacek M; de Tute RM; Van Valckenborgh E; Weston-Bell N; Owen RG; San Miguel JF; Sonneveld P; Johnsen HE;
Haematologica; 2008 Mar; 93(3):431-8. PubMed ID: 18268286
[TBL] [Abstract][Full Text] [Related]
12. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
Mateo G; Castellanos M; Rasillo A; Gutiérrez NC; Montalbán MA; Martín ML; Hernández JM; López-Berges MC; Montejano L; Bladé J; Mateos MV; Sureda A; de la Rubia J; Díaz-Mediavilla J; Pandiella A; Lahuerta JJ; Orfao A; San Miguel JF
Clin Cancer Res; 2005 May; 11(10):3661-7. PubMed ID: 15897562
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotype of normal and myelomatous plasma-cell subsets.
Robillard N; Wuillème S; Moreau P; Béné MC
Front Immunol; 2014; 5():137. PubMed ID: 24744760
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients.
Dragoș ML; Ivanov IC; Mențel M; Văcărean-Trandafir IC; Sireteanu A; Titianu AA; Dăscălescu AS; Stache AB; Jitaru D; Gorgan DL
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886877
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of Bone Marrow Flow Cytometry Analysis in Patients With Plasma Cell Neoplasm in Thailand: A Single Institutional Study.
Limvorapitak W; Srisum-Ang T; Chimres C; Warnnissorn N; Kanitsap N
Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e27-37. PubMed ID: 26796980
[TBL] [Abstract][Full Text] [Related]
17. Flow Cytometric Evaluation of Traditional and Novel Surface Markers for the Diagnosis of Plasma Cell Dyscrasias.
Draxler DF; Wutzlhofer LM; Slavka G; Hübl W; Ludwig H; Schreder M; Reynolds J; Willheim M
Indian J Hematol Blood Transfus; 2019 Oct; 35(4):673-682. PubMed ID: 31741619
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic characterization of normal and abnormal plasma cells in bone marrow of newly diagnosed multiple myeloma patients.
Awasthi NP; Mishra S; Gupta G; Kumari S; Bajpayee A; Singh P; Husain N
Indian J Pathol Microbiol; 2023; 66(2):295-300. PubMed ID: 37077071
[TBL] [Abstract][Full Text] [Related]
19. Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance.
Carulli G; Ottaviano V; Cannizzo E; Giuntini S; Manetti C; Ciancia EM; Azzarà A
Clin Ter; 2012; 163(5):387-92. PubMed ID: 23099966
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic Characterization and Ploidy Analysis of Neoplastic Plasma Cells by Multiparametric Flow Cytometry.
Gupta R; Gupta P; Rahman K; Biswas S; Chandra D; Singh MK; Sarkar MK; Gupta A; Nityanand S
Indian J Hematol Blood Transfus; 2022 Jul; 38(3):473-480. PubMed ID: 35747566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
